RAPT Therapeutics Inc (NASDAQ: RAPT) kicked off on Monday, down -5.31% from the previous trading day, before settling in for the closing price of $1.13. Over the past 52 weeks, RAPT has traded in a range of $0.79-$10.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -36.87% over the last five years. While this was happening, its average annual earnings per share was recorded 81.30%. With a float of $68.90 million, this company’s outstanding shares have now reached $132.01 million.
The firm has a total of 68 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
RAPT Therapeutics Inc (RAPT) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of RAPT Therapeutics Inc is 47.81%, while institutional ownership is 45.20%.
RAPT Therapeutics Inc (RAPT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 81.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 42.80% during the next five years compared to -10.10% drop over the previous five years of trading.
RAPT Therapeutics Inc (NASDAQ: RAPT) Trading Performance Indicators
Take a look at RAPT Therapeutics Inc’s (RAPT) current performance indicators. Last quarter, stock had a quick ratio of 4.87.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.12, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.68 in one year’s time.
Technical Analysis of RAPT Therapeutics Inc (RAPT)
Analysing the last 5-days average volume posted by the [RAPT Therapeutics Inc, RAPT], we can find that recorded value of 0.51 million was lower than the volume posted last year of 0.82 million. As of the previous 9 days, the stock’s Stochastic %D was 40.41%. Additionally, its Average True Range was 0.10.
During the past 100 days, RAPT Therapeutics Inc’s (RAPT) raw stochastic average was set at 11.09%, which indicates a significant decrease from 16.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.68% in the past 14 days, which was lower than the 169.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2642, while its 200-day Moving Average is $2.0900. Now, the first resistance to watch is $1.1400. This is followed by the second major resistance level at $1.2100. The third major resistance level sits at $1.2500. If the price goes on to break the first support level at $1.0300, it is likely to go to the next support level at $0.9900. Should the price break the second support level, the third support level stands at $0.9200.
RAPT Therapeutics Inc (NASDAQ: RAPT) Key Stats
The company with the Market Capitalisation of 141.25 million has total of 34,958K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -116,800 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -18,430 K.
